Ipratropium bromide 0.03% (21mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...
Background: Studies have suggested an increased risk of cardiovascular morbidity and mortality associated with the use of ipratropium bromide. We sought to examine the association between ...
Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...
Only 78 were for tiotropium, while the remaining prescriptions were for ipratropium bromide alone by metered-dose inhaler (55%) or nebulization (7%), or ipratropium bromide in a fixed-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback